{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:58:46Z","timestamp":1792720726334,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":243,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Merz Asia Pacific Pte. Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Delayed inflammatory reactions (DIRs) are rare but increasingly relevant complications of hyaluronic acid (HA) fillers. The aim of this review was to examine the incidence and characteristics of DIRs secondary to HA fillers for facial aesthetic indications. The authors systematically reviewed studies published before December 3, 2024, from PubMed and Embase, using a random-effects meta-analysis model to compute pooled incidence rates of DIR with 95% CIs. Subgroup analyses were performed according to filler crosslinking technology. Case data were analyzed descriptively. The meta-analysis included 242 studies, and case data were supplemented from 71 additional reports. The pooled incidence of DIRs was 0.0005 (95% CI, 0.0002-0.0013) events per patient-years, equivalent to an event occurring for every 2000 patients with 1\u2005year of follow-up. When analyzed by crosslinking technology, incidence rates per patient-year were 0.0044 (95% CI, 0.0006-0.0314) for SHAPE (Stabilized Hyaluronic Acid And Purification Enhancement), 0.0022 (95% CI, 0.0011-0.0043) for Vycross, 0.0007 (95% CI, 0.0003-0.0017) for NASHA (Non-Animal Stabilized Hyaluronic Acid), and 0.0006 (95% CI, 0.0002-0.0025) for HICE (High Concentration Equalized); several filler technologies, including CPM (Cohesive Polydensified Matrix)-based fillers, reported no incident DIR cases during follow-up. The median time to onset was 3\u2005months (range, 2\u2005weeks to 12\u2005years), and time to resolution was 2.9\u2005months (range, 1\u2005day to 6\u2005years). Common presentations included nodules, redness, swelling, and induration. The management often involved hyaluronidase, corticosteroids, and antibiotics. DIRs are rare adverse events following aesthetic HA filler treatments, exhibiting varied times to onset and resolution. Incidence rates appear to vary by crosslinking technology, and awareness of potential differences can contribute to safe and natural outcomes.<\/jats:p>\n                  <jats:p>Level of Evidence: 3 (Therapeutic)<\/jats:p>","DOI":"10.1093\/asjof\/ojag165","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:08:57Z","timestamp":1788250137000},"source":"Crossref","is-referenced-by-count":1,"title":["Incidence and Characteristics of Delayed Inflammatory Reactions Secondary to Hyaluronic Acid Filler Injections: A Systematic Review With Meta-Analysis"],"prefix":"10.1093","volume":"8","author":[{"given":"Jimyung","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5543-5675","authenticated-orcid":false,"given":"Jonathan","family":"Kadouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Pavicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Corduff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Trindade de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton Ming","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0882-0508","authenticated-orcid":false,"given":"Wei Qi","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2026092308521746300_ojag165-B1","doi-asserted-by":"publisher","first-page":"e4362","DOI":"10.1097\/GOX.0000000000004362","article-title":"Treatment of delayed-onset inflammatory reactions to hyaluronic acid filler: an algorithmic approach","volume":"10","author":"Funt","year":"2022","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026092308521746300_ojag165-B2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/CCID.S247171","article-title":"Delayed inflammatory reactions to hyaluronic acid fillers: a literature review and proposed treatment algorithm","volume":"13","author":"Artzi","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092308521746300_ojag165-B3","doi-asserted-by":"publisher","first-page":"e5801","DOI":"10.1097\/GOX.0000000000005801","article-title":"Facial rejuvenation: a global trend of dermatological procedures in the last decade","volume":"12","author":"Liu","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026092308521746300_ojag165-B4","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1007\/s00266-024-04260-2","article-title":"Trends in surgical and nonsurgical aesthetic procedures: a 14-year analysis of the international society of aesthetic plastic surgery\u2014ISAPS","volume":"48","author":"Triana","year":"2024","journal-title":"Aesthetic Plast Surg"},{"key":"2026092308521746300_ojag165-B5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2147\/CCID.S404248","article-title":"The effectiveness of injectable hyaluronic acid in the improvement of the facial skin quality: a systematic review","volume":"16","author":"Ghatge","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092308521746300_ojag165-B6","doi-asserted-by":"publisher","first-page":"NP286","DOI":"10.1093\/asj\/sjz222","article-title":"A systematic review of the literature of delayed inflammatory reactions after hyaluronic acid filler injection to estimate the incidence of delayed type hypersensitivity reaction","volume":"40","author":"Chung","year":"2020","journal-title":"Aesthet Surg J"},{"key":"2026092308521746300_ojag165-B7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/a-2184-6554","article-title":"Etiology of delayed inflammatory reaction induced by hyaluronic acid filler","volume":"51","author":"Lee","year":"2024","journal-title":"Arch Plast Surg"},{"key":"2026092308521746300_ojag165-B8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/DSS.0000000000003473","article-title":"Review of delayed reactions to 15 hyaluronic acid fillers","volume":"48","author":"Kokoska","year":"2022","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s13555-024-01202-3","article-title":"Late-onset reactions after hyaluronic acid dermal fillers: a consensus recommendation on etiology, prevention and management","volume":"14","author":"Baranska-Rybak","year":"2024","journal-title":"Dermatol Ther"},{"key":"2026092308521746300_ojag165-B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/cosmetics11020054","article-title":"Current knowledge and regulatory framework on the use of hyaluronic acid for aesthetic injectable skin rejuvenation treatments","volume":"11","author":"Allen","year":"2024","journal-title":"Cosmetics"},{"key":"2026092308521746300_ojag165-B11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jacbts.2016.03.009","article-title":"Drugs, devices, and the FDA: part 2","volume":"1","author":"Van Norman","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"2026092308521746300_ojag165-B12","first-page":"177","volume-title":"JBI Manual for Evidence Synthesis","author":"Munn","year":"2020"},{"key":"2026092308521746300_ojag165-B13","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"2026092308521746300_ojag165-B14","doi-asserted-by":"publisher","first-page":"e1532","DOI":"10.1097\/GOX.0000000000001532","article-title":"Late-onset inflammatory response to hyaluronic acid dermal fillers","volume":"5","author":"Bhojani-Lynch","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026092308521746300_ojag165-B15","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1097\/DSS.0000000000000257","article-title":"An interesting reaction to a high- and low-molecular weight combination hyaluronic acid","volume":"41","author":"Goodman","year":"2015","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B16","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1111\/jocd.15391","article-title":"Case report of possible iatrogenic Cushing's disease with low-dose prednisone to treat dermal filler hypersensitivity","volume":"21","author":"Grillo","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2026092308521746300_ojag165-B17","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2147\/CCID.S419716","article-title":"Hyaluronic acid fillers and ASIA syndrome: case studies","volume":"16","author":"Owczarczyk-Saczonek","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092308521746300_ojag165-B18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/DSS.0000000000001836","article-title":"Five-year postmarket safety experience with the optimal balance technology range of hyaluronic acid fillers","volume":"46","author":"Jones","year":"2020","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1468-3083.2004.00934.x","article-title":"Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA\u2014Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001","volume":"18","author":"Andr\u00e9","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026092308521746300_ojag165-B20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.joms.2022.09.011","article-title":"Are delayed dermal filler granulomas more common since COVID-19?","volume":"81","author":"Michel","year":"2023","journal-title":"J Oral Maxillofac Surg"},{"key":"2026092308521746300_ojag165-B21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/DSS.0000000000003409","article-title":"Serious adverse events with injectable fillers: retrospective analysis of 7,659 patient outcomes","volume":"48","author":"Kern","year":"2022","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B22","first-page":"50","article-title":"Long-term 23-year global post-marketing safety surveillance review of delayed complications with a supportive hyaluronic acid filler for infraorbital hollow rejuvenation","volume":"17","author":"Siperstein","year":"2024","journal-title":"J Clin Aesthetic Dermatol"},{"key":"2026092308521746300_ojag165-B23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/DSS.0000000000003350","article-title":"Postmarket safety surveillance of delayed complications for recent FDA-approved hyaluronic acid dermal fillers","volume":"48","author":"Cohen","year":"2022","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B24","first-page":"E59","article-title":"Delayed-onset nodules (DONs) and considering their treatment following use of hyaluronic acid (HA)","volume":"14","author":"Convery","year":"2021","journal-title":"Fillers"},{"key":"2026092308521746300_ojag165-B25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/DSS.0000000000002921","article-title":"Preventing and treating adverse events of injectable fillers: evidence-based recommendations from the American Society for Dermatologic Surgery Multidisciplinary Task Force","volume":"47","author":"Jones","year":"2021","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/DSS.0000000000000562","article-title":"Resistant and recurrent late reaction to hyaluronic acid-based gel","volume":"42","author":"Artzi","year":"2016","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/DSS.0000000000000418","article-title":"Delayed-onset nodules secondary to a smooth cohesive 20\u2005mg\/mL hyaluronic acid filler: cause and management","volume":"41","author":"Beleznay","year":"2015","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B28","doi-asserted-by":"publisher","first-page":"NP438","DOI":"10.1093\/asj\/sjad028","article-title":"Making sense of late tissue nodules associated with hyaluronic acid injections","volume":"43","author":"Goodman","year":"2023","journal-title":"Aesthet Surg J"},{"key":"2026092308521746300_ojag165-B29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/DSS.0000000000000434","article-title":"Clinical experience with 11,460\u2005mL of a 20-mg\/mL, smooth, highly cohesive, viscous hyaluronic acid filler","volume":"41","author":"Humphrey","year":"2015","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1021\/acsbiomaterials.5b00181","article-title":"High and low molecular weight hyaluronic acid differentially influence macrophage activation","volume":"1","author":"Rayahin","year":"2015","journal-title":"ACS Biomater Sci Eng"},{"key":"2026092308521746300_ojag165-B31","first-page":"78","article-title":"Hyaluronic acid in inflammation and tissue regeneration","volume":"28","author":"Litwiniuk","year":"2016","journal-title":"Wounds"},{"key":"2026092308521746300_ojag165-B32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/DSS.0000000000000945","article-title":"Delayed adverse subcutaneous reaction to a new family of hyaluronic acid dermal fillers with clinical, ultrasound, and histologic correlation","volume":"43","author":"P\u00e9rez-P\u00e9rez","year":"2017","journal-title":"Dermatol Surg"},{"key":"2026092308521746300_ojag165-B33","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/polym15071649","article-title":"Determination of hyaluronic acid dermal filler impurities using SEM\/EDS analysis","volume":"15","author":"Lee","year":"2023","journal-title":"Polymers (Basel)"},{"key":"2026092308521746300_ojag165-B34","doi-asserted-by":"publisher","first-page":"584595","DOI":"10.2147\/CCID.S584595","article-title":"Exploring the immunological implications of insoluble particulate impurities in hyaluronic acid fillers: integrated physicochemical and histological analyses of the cohesive polydensified matrix range","volume":"19","author":"Lee","year":"2026","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092308521746300_ojag165-B35","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2147\/CCID.S363583","article-title":"Current practices in hyaluronic acid dermal filler treatment in Asia Pacific and practical approaches to achieving safe and natural-looking results","volume":"15","author":"Corduff","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092308521746300_ojag165-B36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/CCID.S50546","article-title":"Dermal fillers in aesthetics: an overview of adverse events and treatment approaches","volume":"6","author":"Funt","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026092308521746300_ojag165-B37","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.15557\/JoU.2020.0044","article-title":"The use of high-frequency ultrasonography for the diagnosis of palpable nodules after the administration of dermal fillers","volume":"20","author":"Mlosek","year":"2021","journal-title":"J Ultrason"},{"key":"2026092308521746300_ojag165-B38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/SCS.0000000000001358","article-title":"Late-onset adverse reactions related to hyaluronic acid dermal filler for aesthetic soft tissue augmentation","volume":"26","author":"Curi","year":"2015","journal-title":"J Craniofac Surg"},{"key":"2026092308521746300_ojag165-B39","doi-asserted-by":"publisher","first-page":"e70784","DOI":"10.1111\/jocd.70784","article-title":"See, touch, feel, and express: achieving safe and natural outcomes with HA fillers\u2014an international consensus","volume":"25","author":"Suwanchinda","year":"2026","journal-title":"J Cosmet Dermatol"}],"container-title":["Aesthetic Surgery Journal Open Forum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asjopenforum\/advance-article-pdf\/doi\/10.1093\/asjof\/ojag165\/70888914\/ojag165.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojag165\/70888914\/ojag165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojag165\/70888914\/ojag165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:52:25Z","timestamp":1790167945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article\/doi\/10.1093\/asjof\/ojag165\/8777317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1093\/asjof\/ojag165","relation":{},"ISSN":["2631-4797"],"issn-type":[{"value":"2631-4797","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"ojag165"}}